This site is intended for healthcare professionals only
LoginRegister
JP Nadda unveils Scheme for Medical Device IndustryJP Nadda unveils Scheme for Strengthening Medical Device Industry
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin bags tentative USFDA nod for Raltegravir Tablets for HIV-1 infection
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA proposes ban of Oral Phenylephrine as OTC for nasal congestion
Max Healthcare profit up nearly 2 percent to Rs 282 crore in Q2Max Healthcare profit up nearly 2 percent to Rs 282 crore in Q2
Fire at Emcure Pharmas Pune Plant, Operations Temporarily HaltedRegular fire safety audit must in Pharma industry, says Telangana Fire Services DG
JnJ Medtech bags USFDA nod for TRUFILL n-BCA Liquid Embolic System for Symptomatic Chronic Subdural HematomaJohnson & Johnson MedTech bags USFDA nod for the Varipulse Pulsed Field Ablation Platform for atrial...
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsGranules India Unit V facility receives USFDA EIR with 'No Action Indicated' status
Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in DogsBoehringer Ingelheim, Broad Institute of MIT and Harvard to develop treatments for people with...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusCDSCO panel Approves AstraZeneca's Protocol Amendment proposal for Datopotamab Deruxtecan study
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealAbbott Gets CDSCO Panel Nod To Manufacture, Market Clarithromycin ER Tablets 1000 mg
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis
Dobustat price review plea rejected by dept of pharmaDept of Pharma upholds NPPA Price Cap on Dobustat Injection
X